Latest Breaking News On - Hus laboratory monitoring - Page 1 : comparemela.com

Post-hoc analysis of Phase 3 study to highlight transfusion avoidance results of SB12 compared to reference eculizumab-treated groups INCHEON, Korea, May .

Eculizumab biosimilarYounsoo kimSamsung bioepisJihyun hanPaola russoHyejin kimHus laboratory monitoringLifecycle safety team leader at samsung bioepisEuropean hematology associationLaboratory monitoringSamsung bioepis co ltdEuropean unionEuropean medicines agencyEuropean commissionAlexion pharmaceuticalsHybrid congress